FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Melissa Rowland-Goldsmith

Research Profile

Physiology

Chemicals & Drugs

Living Beings

Procedures

Neoplasm Transplantation

Disorders

Anatomy

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Melissa A Rowland-Goldsmith; Haruhisa Maruyama; Kei Matsuda; Takenao Idezawa; Monica Ralli; Sonia Ralli; Murray Korc
Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Melissa A Rowland-Goldsmith; Haruhisa Maruyama; T Kusama; S Ralli; Murray Korc
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Melissa A Rowland-Goldsmith; B Holmquist; H L Henry
Genomic cloning, structure, and regulatory elements of the 1 alpha, 25(OH)2D3 down-regulated gene for cyclic AMP-dependent protein kinase inhibitor.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Melissa Rowland-Goldsmith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: Melissa A Rowland-Goldsmith; Haruhisa Maruyama; Kei Matsuda; Takenao Idezawa; Monica Ralli; Sonia Ralli; Murray Korc
Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Molecular cancer therapeutics 2002;1(3):161-7.
2001: Melissa A Rowland-Goldsmith; Haruhisa Maruyama; T Kusama; S Ralli; Murray Korc
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2931-40.
1999: Melissa A Rowland-Goldsmith; B Holmquist; H L Henry
Genomic cloning, structure, and regulatory elements of the 1 alpha, 25(OH)2D3 down-regulated gene for cyclic AMP-dependent protein kinase inhibitor.
Biochimica et biophysica acta 1999;1446(3):414-8.
1997: KR Muralidharan; Melissa A Rowland-Goldsmith; A S Lee; G Park; Anthony W Norman; Helen L Henry; William H Okamura
Inhibitors of 25-hydroxyvitamin D3-1alpha-hydroxylase: thiavitamin D analogs and biological evaluation.
The Journal of steroid biochemistry and molecular biology 1997;62(1):73-8.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.